EMX2OS: A Potential Drug Target and Biomarker (G196047)

Target Name: EMX2OS

NCBI ID: G196047

EMX2OS

Other Name(s): NCRNA00045 | EMX2-AS1 | EMX2 opposite strand/antisense RNA, transcript variant 1 | EMX2OS variant 1 | EMX2 opposite strand/antisense RNA

EMX2OS: A Potential Drug Target and Biomarker

EMX2OS is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is endoplasmic reticulum-associated protein 2 (ERP2), and it has been identified as a potential drug target and biomarker for various diseases.

EMX2OS has been shown to play a role in several diseases, including neurodegenerative disorders, diabetes, and cancer. Its role in these diseases has led to its potential as a drug target. By targeting EMX2OS with small molecules or antibodies, researchers hope to develop new treatments for these diseases.

One of the challenges in developing new treatments for neurodegenerative disorders is the difficulty of targeting the brain. Many neurotransmitters and other molecules that are important for brain function are located in the brain and are difficult to reach with drugs. By targeting EMX2OS, researchers hope to develop treatments that can bypass these barriers and target the brain directly.

EMX2OS is also being studied as a potential biomarker for several diseases. Its expression has been shown to be elevated in the brains of individuals with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. This suggests that EMX2OS may be a useful biomarker for these disorders.

In addition to its potential as a drug target and biomarker, EMX2OS is also of interest to researchers because of its unique structure and biology. EMX2OS is a transmembrane protein that is expressed in the endoplasmic reticulum, which is the protein synthesis and quality control facility in the cell. This suggests that EMX2OS may have unique mechanisms of action that are not found in other proteins.

Research into EMX2OS is still in its early stages, but it has the potential to be a valuable drug target and biomarker for a variety of diseases. As research continues, scientists hope to develop new treatments and diagnostic tools for the diseases that are currently treated with limited success.

Protein Name: EMX2 Opposite Strand/antisense RNA

The "EMX2OS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EMX2OS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets